-+ 0.00%
-+ 0.00%
-+ 0.00%

*TriSalus Life Sciences Expects to Be EBITDA Positive for 2025 and Achieve Positive Cash Flow by 2H of 2025, Extending Total Cash Runway Beyond 2025 >TLSI

Dow Jones·03/27/2025 11:31:00

Please log in to view news